Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Core Informatics and ChemAxon Renew Partnership

Published: Saturday, April 06, 2013
Last Updated: Friday, April 05, 2013
Bookmark and Share
Partnership joins ChemAxon's cheminformatics toolkit suite with Core Informatics' LIMS and ELN.

Core Informatics, a leading provider of data management solutions to the life sciences, molecular diagnostics, and energy industries, and ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, have renewed a multi-year partnership.  The Partnership, established in 2007, joins ChemAxon's growing cheminformatics toolkit suite with Core Informatics' web-based Laboratory Information Management System (Core LIMS) and Electronic Lab Notebook (Core ELN).

The Core LIMS & ELN offer a wide array of features through a flexible component-based architecture that provides organizations with individually tailored solutions to support their data management needs.  The Chemical Registration Application, powered by ChemAxon, enables users within the Core LIMS to lever the power of ChemAxon's cheminformatics toolkits designed to optimize the value of chemistry information in pharmaceutical R&D.  The application's functionality includes, but is not limited to, compound registration, structure visualization and searching, reaction enumeration and calculated properties.

"ChemAxon has been a valued partner over the last 5 years," said Anthony Uzzo, President of Core Informatics. "More importantly, the union of ChemAxon's toolkit suite with the structured data management environment of the Core LIMS continues to provide competitive advantage for our existing and new clients in an important business segment for the organization."

"Our long-standing partnership with Core has been very productive for both companies and to the over 25 customers using the combined platform.  It is a great example of how our chemistry toolkit, which is the partner of choice for companies wishing to extend their chemistry capabilities, helps to deliver a real value for money and high performance solution to the market," said Alex Drijver, CEO of ChemAxon.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Richard R. Duffy Joins Core Informatics As Director of Customer Success
Duffy to be responsible for professional services, support and customer satisfaction.
Saturday, January 11, 2014
Core Informatics Names Josh Geballe as CEO
Geballe joins Core after over a decade at IBM where he held international executive roles spanning general management, finance and strategy.
Thursday, October 03, 2013
Core Informatics Selected as Connecticut Technology Council (CTC) 2013 Marcum Tech Top 40 Award Winner for Second Time
Core Informatics is one of the State's 40 Fastest Growing Tech Companies
Saturday, August 24, 2013
Core Informatics and OpenEye Scientific Software Forge Partnership
New partnership integrates OpenEye cheminformatics software into Core Informatics' web-based LIMS and ELN
Tuesday, May 07, 2013
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!